Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,369 filings

Top spenders & firms Spend by issue

Clear
2A
THE UNIVERSITY OF TEXAS SYSTEM for THE UNIVERSITY OF TEXAS SYSTEM
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Education, Budget/Appropriations, Taxation/Internal Revenue Code, Defense
View →
Q2
FORBES-TATE for CSL BEHRING
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
THE UNIVERSITY OF TEXAS SYSTEM for THE UNIVERSITY OF TEXAS SYSTEM
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Education, Budget/Appropriations, Taxation/Internal Revenue Code, Defense
View →
Q2
CONTINENTAL STRATEGY, LLC for DEXCOM
2nd Quarter (Apr 1 - June 30) 2025 · California · $75,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
FORBES-TATE for COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Agriculture, Banking, Financial Institutions/Investments/Securities, Government Issues
View →
Q2
FORBES-TATE for AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $50,000.00 income
Medical/Disease Research/Clinical Labs, Financial Institutions/Investments/Securities, Health Issues, Budget/Appropriations
View →
Q2
NELSON MULLINS RILEY & SCARBOROUGH for ANBEX, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $15,000.00 income
Medical/Disease Research/Clinical Labs, Energy/Nuclear
View →
Q2
THE CONAFAY GROUP, LLC for REVAGENIX, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues
View →
Q2
A10 ASSOCIATES, LLC for AESTHETIC MEDICAL PROVIDERS OF NEW HAMPSHIRE
2nd Quarter (Apr 1 - June 30) 2025 · New Hampshire · House · Senate · $10,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $40,000.00 income
Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
THE CONAFAY GROUP, LLC for ELUSYS THERAPEUTICS, INC
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $20,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate
Pharmacy, Veterans, Education, Tobacco
View →
Q2
UNIVERSITY OF IOWA for UNIVERSITY OF IOWA
2nd Quarter (Apr 1 - June 30) 2025 · Iowa · House · Senate
Immigration, Homeland Security, Agriculture, Medicare/Medicaid
View →
Q2
VAN SCOYOC ASSOCIATES for AMERICAN ACADEMY OF ADDICTION PSYCHIATRY
2nd Quarter (Apr 1 - June 30) 2025 · Rhode Island · Senate · $30,000.00 income
Alcohol and Drug Abuse, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
THE CONAFAY GROUP, LLC for LIFESCIENCE LOGISTICS
2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate · $30,000.00 income
Medical/Disease Research/Clinical Labs, Disaster Planning/Emergencies
View →
Q2
TWENTY-FIRST CENTURY GROUP, INC. for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $24,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Veterans
View →
Q2
ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Insurance, Budget/Appropriations
View →
Q2
THE ROOSEVELT GROUP for EXTHERA MEDICAL CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Defense, Medical/Disease Research/Clinical Labs, Health Issues
View →
Q2
THE CONAFAY GROUP, LLC for MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
FORBES-TATE for AMGEN USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $80,000.00 income
Budget/Appropriations, Taxation/Internal Revenue Code, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q2
THE CONAFAY GROUP, LLC for ACADIA PHARMACEUTICALS INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income
Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
THE ROOSEVELT GROUP for GUAM REGIONAL MEDICAL CITY
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $15,000.00 income
Medical/Disease Research/Clinical Labs, Defense
View →
Q2
THE ROOSEVELT GROUP for LSU HEALTH SCIENCES FOUNDATION
2nd Quarter (Apr 1 - June 30) 2025 · Louisiana · House · Senate · $50,000.00 income
Defense, Medical/Disease Research/Clinical Labs, Health Issues
View →
Q2
BALLARD PARTNERS for UNIVERSITY OF FLORIDA HEALTH CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Florida · House · Senate · $50,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues
View →
Q2
BURRELL INTERNATIONAL GROUP LLC for OXYGENIUM INC.
2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate
Medical/Disease Research/Clinical Labs
View →
Previous Page 35 of 55 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem